Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Modeling in Therapy

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nature, nurture, and microbes: The development of multiple sclerosis.

Acta neurologica Scandinavica·2017

Same author

Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.

Neurology·2011

Same author

Blood-borne soluble protein antigen intensifies T cell activation in autoimmune CNS lesions and exacerbates clinical disease.

Proceedings of the National Academy of Sciences of the United States of America·2007

Same author

Breaking ignorance: the case of the brain.

Current topics in microbiology and immunology·2006

Same author

The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2006

Same author

Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes.

The American journal of pathology·2001

Same journal

Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project.

Annals of the rheumatic diseases·2026

Same journal

Comparison of the established ASAS definition and preliminary proposed data-driven cut-offs for inflammatory and structural MRI lesions in the sacroiliac joints for eligibility of patients with nonradiographic axial spondyloarthritis in clinical trials.

Annals of the rheumatic diseases·2026

Same journal

Uncovering the heterogeneity of care trajectories leading up to a rheumatoid arthritis diagnosis: a Swedish 10-year study.

Annals of the rheumatic diseases·2026

Same journal

Referral pathways and duration of care for musculoskeletal complaints across Europe: an analysis of primary and secondary care.

Annals of the rheumatic diseases·2026

Same journal

Predictors of unacceptable pain and the impact of sociodemographic factors and comorbidities-results from a large, nationwide cohort of early rheumatoid arthritis.

Annals of the rheumatic diseases·2026

Same journal

Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series.

Annals of the rheumatic diseases·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Modeling Multiple Sclerosis in the Two Sexes: MOG_35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Lessons from multiple sclerosis: models, concepts, observations.

¹Max-Planck-Institute of Neurobiology, Martinsried, Germany. boehlke@neuro.mpg.de

Annals of the Rheumatic Diseases

|December 17, 2008

Summary

This summary is machine-generated.

Experimental autoimmune encephalomyelitis (EAE) models offer insights into multiple sclerosis (MS) but are oversimplified. Reviewing distinct EAE variants and new transgenic models enhances understanding of CNS autoimmunity and potential MS therapies.

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Related Experiment Videos

Last Updated: Jun 27, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Modeling Multiple Sclerosis in the Two Sexes: MOG_35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Area of Science:

Neuroimmunology
Autoimmune Diseases
Translational Medicine

Background:

Multiple sclerosis (MS) is a complex neurological disorder.
Experimental autoimmune encephalomyelitis (EAE) is a common animal model for MS.
Current EAE models do not fully capture MS complexity.

Purpose of the Study:

To review distinct variants of EAE and their utility in modeling human MS.
To discuss new transgenic models for studying CNS autoimmunity.
To evaluate EAE models for MS drug discovery and validation.

Main Methods:

Review of existing literature on EAE variants.
Discussion of novel transgenic EAE models.
Analysis of EAE models for mimicking MS pathology and therapeutic responses.

Main Results:

EAE variants reflect specific aspects of MS pathology.
New transgenic models offer insights into spontaneous autoimmunity and lesion distribution.
Understanding immune cell dynamics in EAE informs MS pathogenesis.
EAE models are valuable for MS drug discovery and validation.

Conclusions:

No single EAE model fully recapitulates MS.
Diverse EAE variants and transgenic models are crucial for comprehensive MS research.
EAE models remain essential tools for advancing MS therapeutics.